logo
  

Chipotle Mexican Grill To Retrain Employees After Latest Illness Scandal

Chipotle Mexican Grill Inc. (CMG) plans to retrain its entire staff after more than 640 customers got sick after eating at a Chipotle restaurant in Ohio last month.

According to CNN, Chipotle CEO Brian Niccol said that starting next week, every Chipotle employee will receive a new training on "food safety and wellness protocols." As of June, the company employed about 70,000 people across roughly 2,450 locations.

Health officials found that a type of bacteria found in food left at unsafe temperatures is the cause of an outbreak of gastrointestinal illness that struck 647 people who ate last month at a Chipotle Mexican Grill restaurant in Ohio.

Between July 26 and July 30, customers of a Chipotle restaurant in Powell, Ohio, just north of Columbus, complained of food poisoning and diarrhea after eating tacos and burrito bowls there.

Local health officials say a bacterium known as Clostridium perfringens caused the outbreak. It is commonly found in beef, poultry, gravies and dried or pre-cooked foods that "are prepared in large quantities and kept warm for a long time before serving," according to the Centers for Disease Control and Prevention.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT